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DNA polymerases are involved in different cellular events, including genome 
replication and DNA repair. In the last few years, a large number of novel DNA 
polymerases have been discovered, and the biochemical analysis of their 
properties has revealed a long list of intriguing features. Some of these 
polymerases have a very low fidelity and have been suggested to play mutator 
roles in different processes, like translesion synthesis or somatic hypermutation. 
The current view of these processes is reviewed, and the current understanding of 
DNA polymerases and their role as mutator enzymes is discussed. 
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INTRODUCTION 
The last 3 years have seen a revolution in the field of DNA replication and repair; unchanged for 
the last years, the list of identified DNA polymerases has expanded to more than twice its original 
number. Along with the discovery of novel members of long-known families and the appearance 
of a new family of enzymes (family Y[1]), the outcome of this burst of discovery has been a 
strongly modified concept of what a DNA polymerase is, and what it does in the cell.  
Until recently, DNA polymerases have been generally conceived as extremely precise 
enzymes whose main cellular function is to faithfully replicate the genome. This point of view 
arose from the study of enzymes as E. coli Pol III, or eukaryotic Pols ε and δ, that are extremely 
processive (i.e., able to polymerize a large number of nucleotides without dissociating from the 
template) and endowed with an accessory 3’-5’ exonucleolytic proofreading, that guarantees a 
high fidelity of synthesis. Under this assumption, the introduction of an incorrect dNMP into 
DNA is a rare and fortuitous event, and mutations arise mainly as a consequence of a defect in the 
replication process.  
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However, the biochemical analysis of the recently discovered polymerases has proven to be 
extremely shocking; most of them have an unprecedented error-proneness, that raises the question 
of their possible function into the cell. While a few have been related to DNA repair, some are 
starting to be considered as mutagenic, and different roles related to the generation of variability 
in the genome are being proposed (Table 1). 
 
V(D)J RECOMBINATION 
Paradoxically, one of the first eukaryotic DNA polymerases to ever be identified[2] was 
mammalian terminal deoxynucleotidyl transferase (TdT), a family X enzyme with polymerization 
properties largely different to what would be expected for a replicative polymerase; its preferred 
substrate is an untemplated DNA. After its first characterizations[3,4,5], TdT has not been 
extensively studied as has been the case for the model enzyme of its family, Pol β[6]. However, 
the interest for the biochemical properties of this enzyme has risen recently[7,8,9], and this year 
Delarue et al. have reported a three-dimensional structure of the enzyme complexed to DNA that 
has allowed the authors to suggest a structural basis for its preference for an untemplated 
substrate[10]. Far from being involved in the replication process and in agreement with its 
properties, the in vivo function of TdT appears to be related to the impressive variability 
associated to immunoglobulin gene chain rearrangements. 
Specific recognition of antigens by lymphocytes is achieved through the action of 
heterodimeric protein receptors known as immunoglobulins (Igs) and T cell receptors (TCR), for 
B and T lymphocytes, respectively. In order to cope with an almost infinite number of different 
possible antigens, lymphocites undergo a number of variability-generating processes that allow a 
somatic diversification of Ig and TCR genes. Starting with a limited set of germline sequences, all 
these processes allow humans to generate a variability of about 1014 and 1018 different clones for 
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Igs and TCRs, respectively[11]. In vertebrates, three such processes are known: V(D)J 
recombination[12,13], somatic hypermutation[14,15], and class-switching recombination[16]. 
V(D)J recombination takes place exclusively in lymphocyte precursors in thymus and bone 
marrow. At a specific stage of lymphocyte development, a mature Ig or TCR gene is assembled 
out of a series of germline gene segments through a process of specific recombination. However, 
recombination by itself does not account for the whole diversifying potential of this process, 
which is mainly guaranteed by the action of a nonorthodox DNA polymerase: TdT. Indeed, 
making use of its peculiar properties, TdT inserts untemplated nucleotides at the junctions of the 
rearranging segments, thus generating a broad spectrum of mutations that allow a greater 
diversity of the antigen receptor “repertoire”.  
SOMATIC HYPERMUTATION 
Further diversification of antigen receptor specificity takes place in mature B lymphocytes. Upon 
antigen recognition, B lymphocytes migrate to secondary lymphoid tissues, where they undergo a 
process of clonal expansion and affinity maturation in structures called germinal centers. This 
affinity maturation step is called somatic hypermutation (SH), and involves the highly frequent 
mutation of the variable regions of B lymphocites Ig genes. The mechanism by which mutations 
are introduced is yet unknown, but it has been suggested that a DNA polymerase with mutagenic 
properties could be the “mutator” enzyme responsible for Ig gene variability[17]. Indeed, recent 
evidence suggests that SH is triggered by a process of site-directed DNA cleavage that would 
generate DNA breaks or nicks throughout the variable regions of the Ig gene. These nicks or 
breaks would thus provide the 3’-OH ends required for DNA polymerase action. Another fact that 
supports the existence of a “mutator” enzyme is the astonishingly high mutation frequency, which 
is otherwise difficult to explain even in the total absence of DNA repair. 
The first proposal of a candidate DNA polymerase was made 2 years ago by Domínguez et 
al.[18], and later supported by other groups[19]. This proposal was based on the observed 
biochemical properties and expression profile of a novel DNA polymerase from family X, DNA 
polymerase mu (Pol µ). This enzyme, which is closely related to TdT (42% amino acid identity), 
also displays a template-independent polymerization capacity, although it largely prefers a 
templated substrate[18]. However, the main fact that points out Pol µ as a candidate 
“hypermutator” is its extremely high infidelity[20,21], together with its expression pattern, that is 
predominant in secondary lymphoid organs.  
Shortly after the discovery of Pol µ, Tippin and Goodman[22] proposed a family Y enzyme, 
pol ι, as a candidate to participate in SH. This hypothesis was originally based on the reduced 
fidelity of this enzyme[23], and was further supported with the observation that the fidelity of this 
enzyme is lowered at the end of DNA templates, suggested to be the substrate of SH[24].  
Shortly after this proposal, another candidate polymerase from family Y emerged. Analysis 
of Xeroderma pigmentosum patients (a deficiency in the repair of UV-damage in DNA) deficient 
in the low fidelity Pol η showed an altered spectra of SH-generated mutations compared to 
normal individuals[25], and the comparison of the in vitro mutation specificity of Pol η with the 
mutational spectra of different Ig genes of healthy individuals suggested that this polymerase 
could play an important role in SH[26].  
The list of candidate DNA polymerases was lastly completed when a recent study proposed 
that Pol ζ, a DNA polymerase with a high mispair extension capacity, might be also essential for 
somatic hypermutation[27]. 
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TRANSLESION SYNTHESIS 
Apart from their proposed role in secondary lymphoid response, Pols η and ι are known to have a 
more general role in the cell: the copying of replication-stalling DNA lesions (such as generated 
by different mutagens as UV light) in a process known as “translesion synthesis” 
(TLS[28,29,30,31]). Most polymerases, including those responsible for chromosome replication, 
are unable to replicate past these bulky DNA lesions, whose persistence in the DNA would cause 
replication to stop. TLS polymerases, however, are able to polymerize past those lesions, 
allowing the replication machinery to circumvent them.  
In eukaryotes, four polymerases are currently believed to participate in the TLS process: three 
TLS polymerases (family Y Pols η, κ and ι), that efficiently catalyze synthesis opposite different 
DNA lesions in vitro[32,33,34,35,36,37], and a mispair extender (family B Pol ζ) that, although 
unable to polymerize opposite lesions, might be sometimes required to extend past the site of 
repair following the action of a TLS polymerase[38]. Moreover, a similar mispair extension 
capacity has recently been reported for Pol κ, thus raising the possibility that both Pol κ and ζ 
might alternatively contribute to the extension activity of TLS[39]. 
The major drawback of the TLS process is that replication past DNA lesions is not costless; 
the damaged nucleotides are frequently miscoding, and thus bypass is achieved at the cost of 
introducing mutations into the genome. Why TLS repair is sometimes preferred over error-free 
forms of repair (such as recombinational repair) is unknown, although it is believed that TSL 
might be limited to situations in which the accumulation of DNA damage exceeds the repair 
capacity of error-free pathways, or to situations in which a DNA lesion is encountered by the 
replication fork.   
However, TLS might not always be an error-prone process. Surprisingly, although being an 
extremely unfaithful enzyme when copying undamaged templates[40,41], DNA polymerase η is 
able to bypass some DNA lesions in an error-free manner[42]. Indeed, lack of Pol η activity in 
humans leads to an increased mutagenesis in response to UV light[43], probably because lesion 
bypass is then carried out by an error-prone polymerase. 
Still, whether a particular TLS polymerase is error-free or error-prone probably depends on 
the nature of the substrate DNA lesion; each of the TLS polymerases appear to have specificity 
for a particular lesion[36,44,45,46,47,48,49], and it is likely that other TLS polymerases might 
compete with the preferred (error-free) polymerase for a specific substrate. For instance, synthesis 
by Pol η can also have mutagenic consequences in some DNA lesions[50,51], and pol η-
expressing yeast cells show increases in their spontaneous mutagenesis rate[52]. Similarly, Pols κ 
and ι show error-free and error-prone activities in vitro on different substrates. 
TRANSLESION SYNTHESIS IN BACTERIA: THE SOS RESPONSE 
The SOS-induced repair pathway has been known for decades to cause the accumulation of 
mutations in E. coli in response to DNA damage[53]. Although the mechanism by which these 
mutations are introduced was unknown, the existence of low-fidelity DNA polymerases was 
already considered as a likely possibility more than 20 years ago[54]. Today, the molecular 
characteristics of SOS-repair are better understood. This pathway is responsible for the induction 
of a number of genes upon DNA damage[55], among which are three E.coli DNA polymerases: 
DNA polymerases II, IV, and V. Although the exact roles of each of these polymerases are still 
not completely elucidated, it seems clear that Pol IV and especially Pol V can be directly 
accounted for the mutagenic consequences of repair; both polymerases carry out error-prone 
TLS[56,57,58]. However, the fact that in bacteria TLS poorly contributes to DNA damage 
resistance[59], has led to the hypothesis that the function of the SOS pathway might be the 
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generation of mutations that would allow the adaptation of a bacterial population to genotoxic 
conditions. Moreover, it is known that E. coli undergoes a process of uninduced or spontaneous 
mutagenesis, of unclear biological significance, and there is evidence that suggests the 
involvement of Pol IV in this process[60,61,62]. 
STRUCTURAL BASIS OF INFIDELITY FOR FAMILY Y POLYMERASES 
Recently, a number of crystal structures of family Y DNA polymerases has provided an 
explanation for the extreme infidelity of these enzymes, and their ability to replicate bulky DNA 
lesions[63,64,66]. Shown in Fig. 1A is the crystal structure of Dpo4 from Sulfolobus solfataricus 
complexed with a DNA template/primer[64]. In contrast with other known polymerase structures, 
Dpo4 presents a small fingers domain, resulting in an extremely open nascent basepair binding 
pocket, that allows to accommodate bulky lesions in the catalytic site, a capacity that is crucial for 
TLS. However, the active site of Dpo4 can accommodate not only DNA lesions, but also (as can 
be seen in Fig. 1B and C) template misalignments. This feature is probably the basis for the 
reduced fidelity of this enzyme[67]. Thus, the intrinsic error-proneness of family Y enzymes on 
undamaged DNA templates might be the unwanted (?) side-effect of their ability to replicate 
bulky lesions. 
OTHER NOVEL POLYMERASES FROM FAMILY X 
Besides Pol µ, already discussed in this paper, the family X of DNA polymerases has grown by 
two other new members: Pol λ[68,69,70] and Pol σ[71]. Although its cellular role is unknown, 
Pol λ seems to be present in all eukaryotes, including plants[68], and is expressed in all tissues 
examined, suggesting a general role for this enzyme. The fact that it has a dRP lyase activity[72] 
(an activity crucial for the Base Excision Repair pathway) together with its biochemical 
characteristics[73] suggest that Pol λ is involved in DNA repair. Its base substitution fidelity 
seems to be relatively high (similar to that of Pol β), but further characterization of the fidelity of 
this enzyme is required to evaluate its potential role in mutagenesis. 
Pol σ has been exclusively characterized in yeast, although it is believed to be present in 
other eukaryotes as well[74]. Its main function seems to be related to sister chromatin 
cohesion[71], but little is known about the biochemical characteristics of this enzyme, that remain 
controversial[75], or about its fidelity of synthesis.  
DISCUSSION 
V(D)J recombination, SH, and TLS are three cellular processes for which the need for a mutator 
polymerase has been invoked. Both V(D)J recombination and SH are clear examples of 
mutagenic processes that are triggered by the cell itself. However, whereas the role of TdT in 
V(D)J recombination has been clearly established, the mutagenic mechanism of SH is currently 
unclear. Although several evidences support the participation of each candidate DNA 
polymerase, there is evidence suggesting that these proposals should be carefully reconsidered. 
Thus, and despite the fact that studies with Pol ι deficient cell lines seem to suggest the 
involvement of this polymerase in the SH process[76], the analysis of the pattern of SH 
mutations[77], the analysis of human deficiencies (Pol η[25]), and the generation of mice ko 
models (Pol µ[78], Pol κ[79]) have failed to prove the involvement of any particular enzyme. 
Instead, these data suggest that SH might depend on the action of more than one DNA 
polymerase, and therefore a single enzyme might be dispensable for the process. The answer to 
this possibility will be found in the generation of ko mice deficient in multiple DNA polymerases.  
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FIGURE 1. A: Ternary complex of Sulfolobus sulfataricus Dpo4 complexed with a DNA template-primer (yellow and brown, 
respectively) and an incoming nucleotide (red). A transparent molecular surface representation of the enzyme shows that the fingers 
and thumb domains are exceptionally small when compared to other DNA polymerases, thus configuring an extremely open nascent 
basepair binding pocket[64]. The nascent basepair binding pocket is able to accommodate a correct basepair (B) as well as a 
misaligned template primer (C). The figure was made with Molscript[80] and GRASP[81] and rendered with Raster3D[82]. 
TLS polymerases, on the other hand, are certainly involved in mutagenesis, at least in 
bacteria and lower eukaryotes. However, the meaning of such a process is still a matter of debate. 
Although these polymerases bear mutagenic consequences to the cell, it can not be discarded that 
the mutations arising as a consequence of TLS are the price to pay for keeping a “safeguard” 
system able to maintain the delicate equilibrium between mutagenesis and cell viability. 
Thus, although it is clear that cells harbor many unfaithful and peculiar enzymes, no 
conclusions can be drawn yet as to the presence of “mutator” DNA polymerases into the cell, 
with the exception of the long-known and sometimes forgotten TdT. Whether one or more of the 
novel enzymes will add to the list of “creative” polymerases, maybe related to a process not yet 
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foreseen, will be one of the most intriguing and exciting questions of the field in the years to 
come. 
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